Aller au contenu
Skip to content
Single Peptide Dosages

Melanotan II (10mg Vial) Dosage Protocol

Melanocortin agonist (tanning / arousal) — research/educational dosing reference.

Single Peptide Dosages Updated November 26, 2025 11 min read Research information only
Melanotan II (10mg Vial) Dosage Protocol
Quick answerDocumented research protocols reconstitute the 10 mg Melanotan II vial with 2 mL of bacteriostatic water, with the research literature referencing a dose of 250 mcg per administration. These values reflect reported experimental handling only and are provided strictly for research use, never as guidance for human use.

Reconstitution calculator

Mix & measure Melanotan II · 10 mg

Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.

Concentrationmg/mL
Draw volumemL
On the syringeunits
Doses / vial 

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →

Dosing & Reconstitution Guide

A single practical dilution with accurate once-daily dosing, step by step

Standard / Loading Approach (2 mL = 5 mg/mL)

Reconstitute: Add 2.0 mL bacteriostatic water to one 10 mg vial → final concentration 5 mg/mL (5,000 mcg/mL).

Loading dose: Begin around 250 mcg/day (some start at 100 mcg) to assess tolerance, then titrate up over the loading phase as UVB exposure drives the tan.

Maintenance: After the tan is established, a maintenance dose of roughly 500–1000 mcg about 1× per week (or as needed) is used to sustain pigmentation.

Easy measuring: At 5 mg/mL, 1 unit = 50 mcg on a U-100 syringe (units = dose ÷ concentration). 250 mcg = 5 units, 500 mcg = 10 units, 1 mg = 20 units.

Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the mixed solution.

Phase / Week(s) Dose & Frequency Volume (U-100 units / mL)
Loading, Week 1 250 mcg (1× daily) 5 units (0.05 mL)
Loading, Week 2 500 mcg (1× daily) 10 units (0.10 mL)
Loading, Weeks 3–4 750 mcg (1× daily) 15 units (0.15 mL)
Loading, Weeks 5–8 1000 mcg / 1 mg (1× daily) 20 units (0.20 mL)
Maintenance (after Week 8) 500–1000 mcg (~1× weekly / as needed) 10–20 units (0.10–0.20 mL)

Ask what generic AI won't
ChatGPT dodges your Melanotan II dosing questions. OpenPeptide answers them.
Documented protocols, exact reconstitution math, and real sources — no lectures, no dead ends.

Why researchers study it

Why Melanotan II draws research interest

These are the directions researchers and the peptide community most often explore Melanotan II for — so you know you’re in the right place. They describe what is being studied, not proven benefits, approved uses, or promised results.

Skin tanning / pigmentation

Studied as a melanocortin agonist that drives melanogenesis (melanin synthesis); investigational and not approved for cosmetic tanning.

Libido / sexual arousal

Investigated for effects on sexual arousal; the related analog bremelanotide (Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women.

Appetite / food intake

Explored in preclinical, animal-only research on melanocortin signaling and appetite suppression / reduced food intake.

UV photoprotection

Researched for UV photoprotection via melanin; the related peptide afamelanotide (Scenesse) is FDA-approved for erythropoietic protoporphyria.

Evidence ranges from early laboratory work to clinical trials depending on the use — the sections below cover the actual data and sources.

01 · At a glance

Quickstart Highlights

Melanotan II is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone (α-MSH) that activates melanocortin receptors — chiefly MC1R (driving melanin production and skin tanning) and MC4R (linked to sexual arousal and appetite effects)[1][2]. It is not approved by any major regulator — an unapproved new drug sold as a research chemical. This educational page outlines a once-daily subcutaneous loading approach in micrograms, with a dilution chosen so doses land on easy-to-read insulin-syringe marks. Presented for research and educational use only.

Reconstitute

Add 2.0 mL bacteriostatic water to one 10 mg vial → 5 mg/mL (5,000 mcg/mL), giving clean unit math on a U-100 syringe.

Loading range

~250 mcg/day to start (some begin at 100 mcg to assess tolerance), titrated up as UVB exposure drives the tan.

Easy measuring

At 5 mg/mL, 1 unit = 50 mcg; 250 mcg = 5 units (0.05 mL), 500 mcg = 10 units, 1 mg = 20 units on a U-100 syringe.

Storage

Lyophilized: store at −20 °C (−4 °F); once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F) and do not freeze the solution.

Important: Start with the Prep & Injection Guide — it covers the preparation and safety basics every protocol on this site assumes.

02 · Dosing & reconstitution

Frequency: one subcutaneous injection each day during the loading phase, titrating up as tolerated, then transitioning to a maintenance dose ~1× per week or as needed. UVB exposure is what actually drives the tan; the peptide increases the pigment response[3]. These figures come from reference protocols, not from approved human dosing.

Dose ceiling: do not exceed ~2 mg/day. Case reports describe serious systemic toxicity and rhabdomyolysis at mega-doses (around 6 mg)[4].

Reconstitution Steps

1

Draw 2.0 mL of bacteriostatic water into a sterile syringe.

2

Release it slowly down the vial’s inner wall to limit foaming.

3

Swirl or roll gently until fully dissolved — don’t shake.

4

Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.

Note

At 5 mg/mL, low loading doses read at just 5–10 units; a 30- or 50-unit insulin syringe can make these small volumes easier to read. Avoid freezing the reconstituted solution, since freeze–thaw can denature the peptide.

03 · What you’ll need

Supplies Needed

Quantities below assume an 8–16 week course: a daily loading phase followed by weekly maintenance.

Peptide Vials (Melanotan II, 10 mg each)

A 10 mg vial covers roughly two weeks of loading at the ~1 mg/day plateau, then several weekly maintenance doses.

  • 8 weeks: ~5 vials
  • 12 weeks: ~8 vials
  • 16 weeks: ~10 vials
Insulin Syringes (U-100, 1 mL)
  • Per injection: 1 syringe
  • 8 weeks (loading daily): ~56 syringes
  • 16 weeks (loading daily): ~112 syringes
Bacteriostatic Water (10 mL bottles)

Use 2.0 mL per 10 mg vial for reconstitution.

  • 8 weeks (5 vials): ~10 mL1–2 bottles
  • 16 weeks (10 vials): ~20 mL2 bottles
Alcohol Swabs

One for the vial stopper + one for the injection site each day.

  • Per injection: 2 swabs
  • 8 weeks (loading daily): ~112 swabs1–2 boxes
Melanotan II (10 mg Vial)
Peptide Vial

View Supplier

Insulin Syringes
Insulin Syringes

View Supplier

Bacteriostatic Water
Bacteriostatic Water

View Supplier

Alcohol Pads
Alcohol Pads

View Supplier

Protocol Overview

A concise summary of the once-daily loading regimen, drawn from commonly cited reference protocols.

  • Goal: Increase skin pigmentation (tanning) via melanocortin (MC1R) receptor activation; MC4R activity also drives arousal and appetite effects[1].
  • Schedule: Daily subcutaneous injections for a 6–8 week loading phase, then maintenance dosing about 1× weekly (or as needed)[3].
  • Dose Range: ~250–1000 mcg per day during loading, titrated gradually to minimize side effects; do not exceed 2 mg/day.
  • Reconstitution: 2.0 mL bacteriostatic water per 10 mg vial gives 5 mg/mL for clean unit measurements.
  • Storage: Keep the dry vial frozen at −20 °C (−4 °F); once mixed, refrigerate at 2–8 °C and do not freeze the solution.

Dosing Protocol

A suggested daily titration approach based on common reference doses.

  • Start: Begin at ~250 mcg once daily (some start at 100 mcg) to gauge tolerability for nausea and flushing.
  • Titrate: Increase by roughly 100–250 mcg every 1–2 weeks as tolerated.
  • Target: Reach about 500–1000 mcg daily by Weeks 4–8; UVB exposure drives the tan.
  • Maintenance: After loading, ~500–1000 mcg about 1× per week (or as needed) sustains pigmentation.
  • Timing: Inject at a consistent time and rotate injection sites systematically.

Storage Instructions

Correct storage is what preserves the peptide’s stability and activity.

  • Lyophilized: Hold the dry vial at −20 °C (−4 °F) in dry, dark conditions and limit moisture exposure[7].
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) and use within about 1–2 weeks; do not freeze the mixed solution, as freezing can denature peptides[8].
  • Handling: Let frozen vials warm to room temperature before opening so condensation won’t form, and keep the solution clear of heat and direct light.
  • Freeze–thaw: Avoid repeated freeze–thaw cycles; prepare aliquots if longer storage is needed.
04 · Good to know

Important Notes

Practical points that keep administration safe and consistent.

  • Sterile technique: Use a fresh sterile U-100 insulin syringe each time and drop it straight into a puncture-proof sharps container afterward.
  • Site rotation: Move between abdomen, thighs and upper arms to reduce local irritation and lipohypertrophy[9].
  • Mole monitoring: Melanotan II can darken existing moles and freckles and prompt new pigmented spots; inspect skin regularly and seek dermatological review of any new or changing lesion — there are concerns about melanoma[6].
  • Dose discipline: Never exceed 2 mg/day; serious systemic toxicity and rhabdomyolysis have been reported at mega-doses (~6 mg)[4].
  • Regulatory note: Melanotan II is not approved by any major regulator — an unapproved new drug sold as a research chemical, not a medicine[6].
05 · How it works

How This Works

Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) that binds and activates melanocortin receptors, particularly MC1R and MC4R[1].

Activation of MC1R on melanocytes stimulates melanin production and distribution, producing increased skin pigmentation. Activation of MC4R in the central nervous system is associated with the drug’s reported sexual-arousal and appetite-suppressing effects[2].

Early human work identified daily doses in the range of roughly 1–2 mg as producing measurable tanning, with conservative protocols starting much lower to limit nausea and flushing[1][2]. Pigmentation accumulates over the loading phase, and UVB exposure is the actual driver of the tan — the peptide amplifies the pigment response[3].

Important caveat: Melanotan II is not an approved medicine in any major jurisdiction. It is an unapproved new drug sold as a research chemical, presented here for research and educational purposes only. Because of its MC1R / pigment effects, there are specific concerns about the darkening of moles and the need to monitor for melanoma.

06 · Daily habits

Lifestyle Factors

Habits that influence outcomes and safety alongside the protocol.

  • UV exposure: Melanotan II increases melanin, but UVB is what drives the tan; always use appropriate sun protection to reduce skin-cancer risk[6].
  • Hydration: Maintain adequate fluid intake, especially if experiencing nausea or appetite suppression.
  • Skin monitoring: Inspect moles and freckles regularly; seek dermatological evaluation if any new or changing pigmented lesions appear[6].
  • Dose discipline: Adhere strictly to conservative dosing; never exceed 2 mg/day to avoid serious adverse effects[4].
07 · What to expect

Potential Effects & Side Effects

Observations from early clinical trials and case reports; human evidence is limited and individual results vary.

Reported Effects

  • Increased pigmentation: Skin tanning via MC1R activation, typically observable after 5–10 daily injections[1].
  • Sexual arousal: MC4R activation can induce spontaneous erections / increased libido in men[5].
  • Appetite suppression: Reduced appetite is commonly reported, also an MC4R-mediated effect.
  • Note on approval: These effects come from unapproved use — Melanotan II is not approved by any major regulator.

Side Effects & Serious Risks

  • Nausea & flushing: Dose-dependent nausea and facial flushing are the most common short-term effects[2].
  • Mole / freckle darkening: Existing moles and freckles can darken and new pigmented spots can appear; theoretical melanoma concerns warrant skin monitoring[6].
  • Dose-limiting toxicity: Severe sympathomimetic symptoms and rhabdomyolysis reported at a 6 mg dose[4].
  • Unapproved status: Not approved by any major regulator; long-term safety in humans is not established.
08 · Injection technique

Injection Technique

General subcutaneous technique, following established clinical best-practice guidance[14].

Pre-Injection Preparation

  • Wash your hands well with soap and water.
  • Wipe the vial stopper with an alcohol swab and let it air-dry.
  • Choose a site (abdomen, thigh, or upper arm) and clean it with a fresh alcohol swab, letting it dry fully.
  • Draw the intended dose, then check for air bubbles and push any out.

Injection Procedure

  • Pinch a skinfold at the chosen site between thumb and forefinger.
  • Insert the needle into the pinch at a 45–90-degree angle (use 45 degrees if the fat layer is thin)[14].
  • Skip aspiration for subcutaneous shots — it isn’t needed[14].
  • Press the plunger slowly and steadily until it’s fully down.
  • Wait 5–10 seconds, then pull the needle straight out to prevent leakage.

Post-Injection Care

  • Drop the used syringe straight into a puncture-proof sharps container — never recap a needle.
  • Return the reconstituted vial to the fridge right away.
  • Rotate the injection site each day to prevent irritation and lipohypertrophy[9].
  • Watch the site for excess redness, swelling, or signs of infection.
10 · The evidence

References

  1. 1
    Journal of Clinical Endocrinology & Metabolism (PubMed)
    Phase I evaluation of Melanotan II, an α-MSH analog, for tanning and melanocortin receptor activation.

    View Source

  2. 2
    Peptides (PubMed)
    Melanotan II dose-finding and tolerability: tanning response with nausea and flushing at higher doses.

    View Source

  3. 3
    British Journal of Dermatology (PubMed)
    Afamelanotide / melanocortin analogs and UV-driven photoprotection and pigmentation.

    View Source

  4. 4
    Clinical Toxicology / Case Reports (PubMed)
    Rhabdomyolysis and severe sympathomimetic toxicity following a high (~6 mg) Melanotan II dose.

    View Source

  5. 5
    International Journal of Impotence Research (PubMed)
    Melanocortin (MC4R) agonism and erectile / sexual-arousal effects of Melanotan II.

    View Source

  6. 6
    U.S. Food & Drug Administration
    Consumer warning: Melanotan II is an unapproved drug; concerns over mole changes and melanoma risk.

    View Source

  7. 7
    Peptide Storage Guide
    Best practices for storing lyophilized peptides (temperature, humidity and light protection).

    View Source

  8. 8
    Bacteriostatic Water Guidance
    Bacteriostatic water for injection: multi-dose vial stability and handling.

    View Source

  9. 9
    NCBI Bookshelf
    Best practices for subcutaneous injection: aseptic technique and site rotation.

    View Source

  10. 10
    Injection Site Rotation (Patient Education)
    Guidance on rotating subcutaneous injection sites to prevent lipohypertrophy and irritation.

    View Source

  11. 11
    Aseptic Technique (CDC)
    Skin antisepsis and aseptic technique for injections.

    View Source

  12. 14
    Centers for Disease Control and Prevention (CDC)
    Subcutaneous injection technique: angle, site and no-aspiration guidance.

    View Source

  13. 15
    Subcutaneous Injection Technique (Patient Education)
    How to administer a subcutaneous injection: clinical technique guidelines.

    View Source

  14. 16
    Prime Lab Peptides
    Melanotan II (10 mg) product page — purity specifications and certificates of analysis.

    View Source

Read the complete guide Peptide Dosage Chart Where to source it Which suppliers we lab-tested — purity, price and shipping compared
FAQ

Melanotan II — frequently asked questions

How do I reconstitute a 10 mg vial of Melanotan II?

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units.

How much bacteriostatic water should I add to Melanotan II?

There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units.

What do the "units" on an insulin syringe mean?

On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand.

How should I store Melanotan II after mixing?

Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product.

How many doses does a 10 mg vial of Melanotan II provide?

Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose.

Is Melanotan II approved for human use?

No. Melanotan II is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Stay precise

New protocols & dosing updates

Reconstitution charts, new peptide protocols and safety updates — straight to your inbox. No spam, unsubscribe anytime.